When pain management isn't the whole answer
Long-term opioid therapy keeps patients functional. It doesn't always address the broader clinical context.
For physicians who treat the whole picture:
pain, dependence, and recovery.
We work with pain management physicians, orthopedic surgeons, and physicians supporting patients reducing opioid dependence.
We compound formulations researched for acute and chronic care, backed by twenty years of experience and documentation with every batch.
Our Pain Management Services
-
Researchers have studied naltrexone at different dose levels for its role in opioid-based pain therapy.
-
Pain rarely shows up alone. Many patients are also managing weight, metabolic, musculoskeletal, and dependency factors at the same time.
-
Researchers have studied various compounds in the context of tissue and musculoskeletal recovery.
Compounding is most powerful when the pharmacy thinks about the patient the way the physician does.
-
Twenty years of specialty compounding across complex, patient-specific formulations.
-
Pharmacists available for clinical consultation, not just order fulfillment.
-
±5% potency tolerance, USP 795/797/800, independent third-party testing.
-
Certificate of Compliance with every batch, sourcing and formulation documentation on request.
GenoGenRx compounds ultra-low-dose and low-dose naltrexone alongside peptides studied for recovery and metabolic support, at the dose levels physicians need for pain, dependence, and recovery care.
Access starts with compounding
